|
|
|
|
Key cellular defect in protein synthesis can lead to cancer susceptibility
cancer rates continue to decline in racial and ethnic populationsGood news in the fight against cancer!A new report from leading health and cancer organizations sho...Researchers explore optimal induction therapies for managing blood cancerThere have been...
|
|
|
BioSante Announces Positive Leukemia Vaccine Results
Johns Hopkins Researchers Say Vaccine Appears to 'Mop Up' Leukemia Cells Gleevec Leaves Behind LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--BioSante Pharmaceuticals, Inc.(NASDAQ: BPAX) today announced positive results of a human clinical study that show that...
|
|
|
::: BioSante Announces Positive Leukemia Vaccine Results
Johns Hopkins Researchers Say Vaccine Appears to 'Mop Up' Leukemia Cells Gleevec Leaves Behind LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--BioSante Pharmaceuticals, Inc.(NASDAQ: BPAX) today announced positive results of a human clinical study that show that...
|
|
|
BioSante Announces Positive Leukemia Vaccine Results
BioSante Pharmaceuticals, Inc.(NASDAQ: BPAX) announced positive results of a human clinical study that show that its GVAX Leukemia vaccine may be able to reduce or eliminate the last remaining cancer cells in some chronic myeloid leukemia (CML) patients...
|
|
|
News and FDA Updates for Bioject Medical (OTC:BJCT), BioSante (NASDAQ:BPAX), Caraco (NYSE:CPD)
BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors has Healthcare stock news and updates to its calendar database of Clinical Trials...
|
|
|
Medical News: BioSante Announces Positive Leukemia Vaccine Results
BioSante Pharmaceuticals, Inc.(NASDAQ: BPAX) announced positive results of a human clinical study that show that its GVAX Leukemia vaccine may be able to reduce or eliminate the last remaining cancer cells in some chronic myeloid leukemia (CML) patients...
|
|
|
News and FDA Updates for Bioject Medical (OTC:BJCT), BioSante (NASDAQ:BPAX), Caraco (NYSE:CPD)
BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors has Healthcare stock news and updates to its calendar database of Clinical Trials...
|
|
|
BioSante rallies on study; drug stocks slip
Story Quotes Comments Screener AlertEmail Print BOSTON (MarketWatch) -- Shares of BioSante Pharmaceuticals Inc.rose sharply in late Thursday trading, powered by a study that showed its GVAX Leukemia vaccine appeared to be effective in battling chronic...
|
|
|
BiomedReports: News and FDA Updates for Bioject Medical (OTC:BJCT), BioSante (NASDAQ:BPAX), Caraco (NYSE:CPD)
BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors has Healthcare stock news and updates to its calendar database of Clinical Trials...
|
|
|
BioSante Announces Positive Leukemia Vaccine Results
Johns Hopkins Researchers Say Vaccine Appears to Mop Up Leukemia Cells Gleevec Leaves Behind LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--Mar 11, 2010 - BioSante Pharmaceuticals, Inc.(NASDAQ: BPAX) today announced positive results of a human clinical study...
|
|
|
No Cure For Pfizer From Cancer
The drug industry's big bet on expensive targeted cancer drugs may be starting to fail.In recent years, companies like Pfizer have put more targeted cancer drugs into trials than ever before. (See ) The drugs aim at one or more defective growth promoting...
|
|
|
Cancer Drugs May Not Cure Pfizer
The drug industry's big bet on expensive targeted cancer drugs may be starting to fail.In recent years, companies like Pfizer have put more targeted cancer drugs into trials than ever before. (See ) The drugs aim at one or more defective growth promoting...
|
|
|
Cancer Drugs May Not Cure Pfizer
The drug industry's big bet on expensive targeted cancer drugs may be starting to fail.In recent years, companies like Pfizer have put more targeted cancer drugs into trials than ever before. The drugs aim at one or more defective growth promoting genes...
|
|
|
Pfizer says clinical trials for Sutent did not meet expectations; halts additional cancer treatment study
NEW YORK (Mar.12) Two clinical trials of a Pfizer drug for treating advanced breast cancer have failed, Pfizer announced Thursday. The worlds largest drug maker said two phase 3 trials in which Sutent (sunitinib malate) was added to chemotherapy did not...
|
|
|
BiomedReports: News and FDA Updates for Bioject Medical (OTC:BJCT), BioSante (NASDAQ:BPAX), Caraco (NYSE:CPD)
Symbols: BPAX, CPD Do you know when to trade BPAX & CPD?Pasadena, CA, Mar 12, 2010 (M2 PRESSWIRE via COMTEX) -- BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a...
|
|
|
BeaconEquity.com: BPAX incurs net loss of $6.4M for quarter ended September 30, 2009
BioCryst Pharmaceuticals announces fourth-quarter and full-year 2009 financial resultsBioCryst Pharmaceuticals, Inc.today announced financial results for the fourth quarter and year end...Exactech to fund more than $100,000 in research and residency...
|
|
|
Biotech Stock Alert for BioSante Pharmaceuticals Inc. Issued by Beacon Equity
(GLOBE NEWSWIRE) -- BeaconEquity.com announces an investment report featuring biotechnology company BioSante Pharmaceuticals Inc.(Nasdaq:BPAX). The report includes financial, comparative and investment analyses, and pertinent industry information you need...
|
|
|
Biotech Stock Alert for BioSante Pharmaceuticals Inc. Issued by B...
Company: BioSante Pharmaceuticals, Inc.(BPAX) BeaconEquity.com announces an investment report featuring biotechnology company BioSante Pharmaceuticals Inc. (Nasdaq:BPAX). The report includes financial, comparative and investment analyses, and pertinent...
|
|
|
Biotech Stock Alert for BioSante Pharmaceuticals Inc. Issued by Beacon Equity
(GLOBE NEWSWIRE) -- BeaconEquity.com announces an investment report featuring biotechnology company BioSante Pharmaceuticals Inc.(Nasdaq:BPAX). The report includes financial, comparative and investment analyses, and pertinent industry information you need...
|
|
|
Biotech Stock Alert for BioSante Pharmaceuticals Inc. Issued by Beacon Equity
(GLOBE NEWSWIRE) -- BeaconEquity.com announces an investment report featuring biotechnology company BioSante Pharmaceuticals Inc.The report includes financial, comparative and investment analyses, and pertinent industry information you need to know to make...
|
|
|
Biotech Stock Alert for BioSante Pharmaceuticals Inc. Issued by Beacon Equity
(GlobeNewswire via COMTEX) ----BeaconEquity.com announces an investment report featuring biotechnology company BioSante Pharmaceuticals Inc.(Nasdaq:BPAX). The report includes financial, comparative and investment analyses, and pertinent industry...
|
|
|
Biotech Stock Alert for BioSante Pharmaceuticals Inc. Issued by Beacon Equity
(GLOBE NEWSWIRE) -- BeaconEquity.com announces an investment report featuring biotechnology company BioSante Pharmaceuticals Inc.(Nasdaq:BPAX - News). The report includes financial, comparative and investment analyses, and pertinent industry information...
|
|
|
Biotech Stock Alert for BioSante Pharmaceuticals Inc. Issued by
(GLOBE NEWSWIRE) -- BeaconEquity.com announces an investment report featuring biotechnology company BioSante Pharmaceuticals Inc.(Nasdaq:BPAX). The report includes financial, comparative and investment analyses, and pertinent industry information you need...
|
|
|
Biotech Stock Alert for BioSante Pharmaceuticals Inc. Issued by Beacon Equity
(GlobeNewswire via COMTEX) -- BeaconEquity.com announces an investment report featuring biotechnology company BioSante Pharmaceuticals Inc.(Nasdaq: BPAX | Quote | Chart | News | PowerRating). The report includes financial, comparative and investment...
|
|
|
Biotech Stock Alert for BioSante Pharmaceuticals Inc. Issued by Beacon Equity
(GLOBE NEWSWIRE) -- BeaconEquity.com announces an investment report featuring biotechnology company BioSante Pharmaceuticals Inc.(Nasdaq: BPAX). The report includes financial, comparative and investment analyses, and pertinent industry information you need...
|
